InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M1C7)
InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M1C7) 

InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M1C7)

  • Catalog number: RA14496
  • Availability: In Stock
  • $370.00

  • Ex Tax: $370.00


Available Options

Qty

Description: InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M1C7) [M1C7] (RA14496) is a human monoclonal antibody detecting F in ELISA, Neutralization.
Host species: Human
Isotype: IgG1, kappa
Species reactivity: Human respiratory syncytial virus (HRSV), Human metapneumovirus (HMPV)
Form: Liquid
Storage buffer: 0.01M PBS, pH 7.4.
Concentration: 1 mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: ELISA, Neutralization
Target: F, Fusion glycoprotein F
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: Please contact with the lab for this information.
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names:
Background: Fusion glycoprotein F0 is a ~63 kDa protein. Inactive precursor that is cleaved at two sites by a furin-like protease to give rise to the mature F1 and F2 fusion glycoproteins.
Note: For research use only. Not suitable for clinical or therapeutic use.

Images

  • SDS-PAGE for InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M1C7)
    SDS-PAGE

    SDS-PAGE for InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M1C7)

  • Bioactivity for InVivoMAb Anti-HRSV/hMPV Fusion glycoprotein Neutralizing Antibody (M1C7)
    Bioactivity

    Detects recombinant HRSV-A2 Pre-F/Fusion glycoprotein F0 (Catalog No: PV10554) in indirect ELISA

Be the first to write a review for this product.

Write a review

Note: HTML is not translated!
Bad           Good